Tetrahydropyrimidine derivatives

The invention comprises compounds of the general formula: <FORM:0868030/IV (b)/1> wherein R represents an amino group and R1 an hydroxy group or R represents as C1-5 alkyl radical optionally substituted by halogen or by a morpholino radical and R1 represents a C1-5 alkoxy, a C1-5 alkyl or an a...

Full description

Saved in:
Bibliographic Details
Main Authors SWAIN GEOFFREY, HULL ROY
Format Patent
LanguageEnglish
Published 22.05.1962
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention comprises compounds of the general formula: <FORM:0868030/IV (b)/1> wherein R represents an amino group and R1 an hydroxy group or R represents as C1-5 alkyl radical optionally substituted by halogen or by a morpholino radical and R1 represents a C1-5 alkoxy, a C1-5 alkyl or an anilino radical and the preparation (a) of those compounds wherein R represents an amino group, or a C1-5 alkyl radical by interaction of urea, 5-nitro-2-furaldehyde o or a functional derivative thereof and a compound R1CH2COR2 wherein R1 represents a cyano radical and R2 an hydroxy group, or R1 represents the radical R3CO wherein R3 represents a C1-5 alkyl radical and R2 a C1-5 alkoxy or an anilino radical, under acidic conditions; (b) of those compounds wherein R represents a C1-5 alkyl optionally substituted by halogen or by a morpholino radical by halogenating a compound of the general formula: <FORM:0868030/IV (b)/2> wherein R4 represents a C1-5 alkyl radical followed, if necessary, by reaction of the halogeno compound with morpholine; and (c) of those compounds wherein R and R1 represent methyl radicals by heating 5-nitro-2-furaldehyde diureide with acetylacetone in the presence of a mineral acid. The Provisional Specification discloses compounds of the general formula of the products above wherein additionally R represents a hydrocarbon radical and R1 a hydrocarbon, a hydrocarbonoxy or an amino radical, optionally substituted. 5-Nitro-2-furaldehyde diureide is obtained from 5-nitro-2-furaldehyde and urea.ALSO:Pharmaceutical compositions comprise in addition to an inert diluent or carrier one or more of the compounds of the general formula <FORM:0868030/VI/1> wherein R represents an amino group and R1 an hydroxy group or R represents a C1-5 alkyl group optionally substituted by halogen or by a morpholino radical and R1 a C1-5 alkyl, a C1-5 alkoxy or an anilino group. Compositions include ointments, creams, jellies and lotions suitable for application to the eye.
AbstractList The invention comprises compounds of the general formula: <FORM:0868030/IV (b)/1> wherein R represents an amino group and R1 an hydroxy group or R represents as C1-5 alkyl radical optionally substituted by halogen or by a morpholino radical and R1 represents a C1-5 alkoxy, a C1-5 alkyl or an anilino radical and the preparation (a) of those compounds wherein R represents an amino group, or a C1-5 alkyl radical by interaction of urea, 5-nitro-2-furaldehyde o or a functional derivative thereof and a compound R1CH2COR2 wherein R1 represents a cyano radical and R2 an hydroxy group, or R1 represents the radical R3CO wherein R3 represents a C1-5 alkyl radical and R2 a C1-5 alkoxy or an anilino radical, under acidic conditions; (b) of those compounds wherein R represents a C1-5 alkyl optionally substituted by halogen or by a morpholino radical by halogenating a compound of the general formula: <FORM:0868030/IV (b)/2> wherein R4 represents a C1-5 alkyl radical followed, if necessary, by reaction of the halogeno compound with morpholine; and (c) of those compounds wherein R and R1 represent methyl radicals by heating 5-nitro-2-furaldehyde diureide with acetylacetone in the presence of a mineral acid. The Provisional Specification discloses compounds of the general formula of the products above wherein additionally R represents a hydrocarbon radical and R1 a hydrocarbon, a hydrocarbonoxy or an amino radical, optionally substituted. 5-Nitro-2-furaldehyde diureide is obtained from 5-nitro-2-furaldehyde and urea.ALSO:Pharmaceutical compositions comprise in addition to an inert diluent or carrier one or more of the compounds of the general formula <FORM:0868030/VI/1> wherein R represents an amino group and R1 an hydroxy group or R represents a C1-5 alkyl group optionally substituted by halogen or by a morpholino radical and R1 a C1-5 alkyl, a C1-5 alkoxy or an anilino group. Compositions include ointments, creams, jellies and lotions suitable for application to the eye.
Author SWAIN GEOFFREY
HULL ROY
Author_xml – fullname: SWAIN GEOFFREY
– fullname: HULL ROY
BookMark eNrjYmDJy89L5WRQCEktKUrMqEwpyi-oLMrMzUzJzEtVSEktyixLLMksSy3mYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxocHGBsZmBubGjsaEVQAA-_InQQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US3036073A
GroupedDBID EVB
ID FETCH-epo_espacenet_US3036073A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:02:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US3036073A3
Notes Application Number: US19590850024
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19620522&DB=EPODOC&CC=US&NR=3036073A
ParticipantIDs epo_espacenet_US3036073A
PublicationCentury 1900
PublicationDate 19620522
PublicationDateYYYYMMDD 1962-05-22
PublicationDate_xml – month: 05
  year: 1962
  text: 19620522
  day: 22
PublicationDecade 1960
PublicationYear 1962
RelatedCompanies IMPERIAL CHEMICAL INDUSTRIES LIMITED
RelatedCompanies_xml – name: IMPERIAL CHEMICAL INDUSTRIES LIMITED
Score 2.3230577
Snippet The invention comprises compounds of the general formula: <FORM:0868030/IV (b)/1> wherein R represents an amino group and R1 an hydroxy group or R represents...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title Tetrahydropyrimidine derivatives
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19620522&DB=EPODOC&locale=&CC=US&NR=3036073A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUw1TDRISjYAln6JZrom5klpupbmaSnA7G6enGQKOgEvFbxA1s_MI9TEK8I0gokhA7YXBnxOaDn4cERgjkoG5vcScHldgBjEcgGvrSzWT8oECuXbu4XYuqilQLaLmRkZANsTai5Otq4B_i7-zmrOzrahwWp-QbagkhqYmh2ZGVhBjWjQKfuuYU6gPSkFyBWKmyADWwDQrLwSIQam1DxhBk5n2L1rwgwcvtDpbiATmvOKRRgUQlJLgOVCZUpRfkEl6CouYJ2TqpACTD9l4KO7i0UZ5N1cQ5w9dIFWxcN9FR8aDHOTsRgDC7CvnyrBoGCWYgwMPWAImVskmpglmloYmJslGSaapJoYWqYkJiVKMkjgMkUKt5Q0AxcobECT3kZGMgwsJUWlqbLAurQkSQ4cDACiJHl7
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR1NT8Iw9AXRiDdFDX6yg9ltcRv7YIfFyMYyFQaRzXBb2rUEL7DA1PDvfatMvXBr2uS1fXkffX1fAHcO14hKMxWlH7EUw6YzxbFnDNndzqhZVsDjIkA2ssLEeJ6a0xrMq1wYUSf0SxRHRI7KkN8LIa_zv08sX8RWru_pO04tH4LY9WX2ky5m6Sq-J2S_5_bHI3_kyZ7nJhM5enVLSY3U_LgH-zYahMJQeuuVOSn5f4USHMPBGGEtihOo8UUTGl7Vd60Jh8OtuxuHW85bn4IU8wLlwoatlvmmbMWFOodLDOnnU5TuXp9BO-jHXqjgVunvrdJkUp2pcw51tPV5CySLdRB7iCG7SwyLmF3VtqhGDG5oDiOUXEBrF5TL3UttaITxcJAOnqKXKzgq8VQ6wHX9GurF6oPfoF4t6K1AyTd0mnxl
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Tetrahydropyrimidine+derivatives&rft.inventor=SWAIN+GEOFFREY&rft.inventor=HULL+ROY&rft.date=1962-05-22&rft.externalDBID=A&rft.externalDocID=US3036073A